Authors
Latest:
Stigma in Epilepsy in 2023: How Far Have We Come?In recent conversations with experts in epilepsy, the impact of stigmatization remains high for patients and ongoing efforts by clinicians to address this issue in the clinical setting has been underscored, despite the global lack of awareness about new treatments and other resources.
Latest:
Targeting Disease Modification for Psoriasis and Psoriatic ArthritisMedical experts engage in a discussion surrounding the treatment and management of patients diagnosed with psoriasis and psoriatic arthritis.
Latest:
Challenges in Managing Type 1 Diabetes and Pressing Need for New TherapiesDrs Diana Isaacs and Natalie Bellini discuss the everyday challenges of managing type 1 diabetes and underscore the need for new treatments to improve the quality of life for people living with type 1 diabetes
Latest:
Treatment Decisions and its Relation to Patient AccessibilityFinal thoughts from expert KOLs regarding treatment decisions and how they relate to patient accessibility when manage dyslipidemia.
Latest:
Reconsidering Standard of Care for HypercortisolismPanelists discuss how treating hypercortisolism in patients may have long-term effects on glycemic control and overall health, potentially influencing future standards of care for difficult-to-control Type 2 diabetes, while emphasizing the need for clinicians to carefully manage such patients as ongoing research continues.
Latest:
Emerging Treatments of Anhedonia in Patients with Major Depressive DisorderDr Andrew Cutler and Dr Greg Mattingly comment about emerging treatments to treat anhedonia and highlight lifestyle modifications that support the wellbeing of patients with Major Depressive Disorder.
Latest:
Ketamine for the Treatment of MDDRyan Oakley, MD, takes a closer look at the recent history of ketamine in depression. He also explores the differences between ketamine and esketamine.
Latest:
Optimizing Treatment Outcomes in Retinal Vein Occlusion (RVO)A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.
Latest:
Helping Your Patients Avoid the Migraine Trigger TrapForget what you think you know about red wine or chocolate ‘activating’ migraine. Many commonly accepted “triggers” aren’t triggers at all.
Latest:
Bariatric Surgery in Patients Hospitalized with Decompensated Cirrhosis: A Nationwide AnalysisThe retrospective analysis highlights improved outcomes among patients with obesity and a history of bariatric surgery hospitalized with decompensated cirrhosis.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Reducing the Stigma of Unplanned Pregnancy Starts with a ConversationAn unplanned pregnancy can translate into a multitude of health factors and risks for both the mother and the baby.
Latest:
Quantifying the Association Between Anxiety and Depressive Features and High Disease Activity Scores in SLEAnxiety and depression can limit engagement with healthcare or treatment leading to later diagnosis, poor treatment adherence, and poor disease control with associated negative sequelae.
Latest:
The Burden of Treatment Resistant DepressionRyan J. Wakim, MD, DFAPA, explores the causes and diagnostic criteria for treatment resistant depression. He also discusses the importance of comprehensive assessment and personalized approaches to care.
Latest:
Generational Trends and Innovations in Retinal Disease TreatmentA panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.
Latest:
Final Thoughts: Awareness and Communication in DiabetesThought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
Latest:
Addressing Current Treatment Gaps in Pediatric and Adult IBDCurrent treatment limitations in inflammatory bowel disease and the rationale for earlier initiation and use of newer therapies to manage pediatric and adult patients.
Latest:
Community Provider Engagement in HCVMamta Jain, MD, MPH, summarizes community outreach efforts regarding the training and education of health workers.
Latest:
Emerging Treatments Over the Horizon for IBDJessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
Latest:
Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MDTaher Modarressi, MD, sits down with hosts to share tips and practical nuggets for cardiometabolic health specialists to optimize prescription and adherence to newer therapies.
Latest:
Building Confidence in Biosimilars in OphthalmologyRishi P. Singh, MD; and Michael A. Klufas, MD, discuss how to gain both physician and patient trust when it comes to using biosimilars to treat ophthalmologic conditions.
Latest:
Rheumatoid Arthritis Quiz: TNF InhibitorsHow well do patients with rheumatoid arthritis adhere to treatment with a TNF inhibitor and how likely and long lasting is remission? Test your knowledge with this quiz.
Latest:
Looking Into the Future of Lipid ManagementDr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
